A novel mechanism in suppression of erythropoiesis during inflammation: A crucial role of RCAS1

European Journal of Haematology

Volumn 74, Issue 5, 2005, Pages 365-373

  Suehiro, Youko ^a   Muta, Koichiro ^b   Nakashima, Manabu ^a   Abe, Yasunobu ^b   Shiratsuchi, Motoaki ^a   Shiokawa, Satoshi ^a   Ikuyama, Shoichiro ^a   Yoshikawa, Yasuji ^a   Watanabe, Takeshi ^a   Nishimura, Junji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Anemia of chronic disease; Apoptosis; Erythroid progenitors; Inflammation; Macrophages; RCAS1

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANEMIA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, NEOPLASM; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 20244368233     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00389.x     Document Type: Article

References (38)

1. SONODA K, NAKASHIMA M, SAITO T, AMADA S, KAMURA T, NAKANO H, WATANABE T. Establishment of new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995;6:1099-1104.
2. SONODA K, NAKASHIMA M, KAKU T, KAMURA T, NAKANO H, WATANABE T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-1509.
3. NAKASHIMA M, SONODA K, WATANABE T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999;5:938-942.
4. SONODA K, KAKU T, KAMURA T, NAKASHIMA M, WATANABE T, NAKANO H. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 1998;4:1517-1520.
5. KAKU T, SONODA K, KAMURA T, et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999;5:1449-1453.
6. SONODA K, KAKU T, HIRAKAWA T, KOBAYASHI H, AMADA S, SASAKI K, NAKASHIMA M, WATANABE T, NAKANO H. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000;79:424-429.
7. TAKAHASHI H, IIZUKA H, NAKASHIMA M, WADA T, ASANO K, ISHIDA-YAMAMOTO A, WATANABE T. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001;26:140-144.
8. IWASAKI T, NAKASHIMA M, WATANABE T, YAMAMOTO S, INOUE Y, YAMANAKA H, MASTUMURA A, IUCHI K, MORI T, OKADA M. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-493.
9. IZUMI M, NAKANISHI Y, YOSHINO I, NAKASHIMA M, WATANABE T, HARA N. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446451.
10. NOGUCHI K, ENJOJI M, NAKAMUTA M, et al. Expression of tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
11. OHSHIMA K, MUTA K, NAKASHIMA M, HARAOKA S, TUTIYA T, SUZUMIYA J, KAWASAKI C, WATANABE T, KIKUCHI M. Expression of human tumor associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infections potential mechanism of immune evasion. Int J Cancer 2001;93:91-96.
12. OHSHIMA K, NAKASHIMA M, SONODA K, KIKUCHI M, WATANABE T. Expession of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001;123:481-486.
13. KUBOKAWA M, NAKASHIMA M, YAO T, ITO KI, HARADA N, NAWATA H, WATANABE T. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
14. GORDON MY. Extracellular matrix of the bone marrow microenvironment. Br J Haematol 1988;70:1-4.
15. WICKREMASINGHE RG, HOFFBRAND AV. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies. Blood 1999;93:3587-3600.
16. SADAHIRA Y, YOSHINO T, MONOBE Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J Exp Med 1995;181:411-415.
17. SADAHIRA Y, MORI M. Role of the macrophage in erythropoiesis. Pathol Int 1999;49:841-848.
18. HANSPAL M, HANSPAL JS. The association of erythroblasts with macrophages promotes erythroid proliferation and maturation: 30-kD heparin-binding protein is involved in this contact. Blood 1994;84:3494-3504.
19. DAI CH, KRANTZ SB. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid cells. Blood 1999;93:3309-3316.
20. ROODMAN GD, BIRD A, HUTZLER D, MONTGOMERY W. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 1987;15:928-935.
21. MATSUSHIMA T, NAKASHIMA M, OSHIMA K, ABE Y, NISHIMURA J, NAWATA H, WATANABE T, MUTA K. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001;98:313-321.
22. SAWADA K, KRANTZ SB, KANS JS, DESSYPRIS EN, SAWYER S, GLICK AD, CIVIN CI. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 1987;80:357-366.
23. SAWADA K, KRANTZ SB, DESSYPRIS EN, KOURY ST, SAWYER ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989;83:1701-1709.
24. CHOI I, MUTA K, WICKREMA A, KRANTZ SB, NISHIMURA J, NAWATA H. Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. Blood 2000;95:3742-3749.
25. ENJOJI M, NAKASHIMA M, NISHI H, et al. The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J Hepatol 2002;36:786-792.
26. MUTA K, KRANTZ SB, BONDURANT MC, WICKREMA A. Distinct role of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 1994;94:34-43.
27. MUTA K, KRANTZ SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 1993;156:264-271.
28. MUTA K, KRANTZ SB, BONDURANT MC, DAI CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995;86:572-580.
29. MEANS RT, KRANTZ SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
30. DAI CH, PRINCE JO, BRUNNER T, KRANTZ SB. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood 1998;91:1235-1242.
31. JELKMAN W, PAGEL H, WOLFF M, FANDREY J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1991;50:301-308.
32. TANIGUCHI S, DAI CH, PRICE JO, KRANTZ SB. Interferon-γ downregulates stem cell factor and erythropoietin receptors but not insulinlike growth factor-I receptors in human erythroid colony-forming cells. Blood 1997;90:2244-2252.
33. KIENER PA, DAVIS PM, STARLIG GC, MEHLIN C, KLEBANOFF SJ, LEDBETTER JA, LILES WC. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med 1997;185:1511-1516.
34. BROWN SB, SAVILL J. Phagocytosis triggers macrophages release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol 1999;162:480-485.
35. HALAAS O, VIK R, ASHKENAZI A, ESPEVIK T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol 2000;51:244-250.
36. WANG CQ, UDUPA KB, XIAO H, LIPSCHITZ DA. Evidence suggesting a negative regulatory role for macrophages in murine erythropoiesis in vivo. Exp Hematol 1994;22:370-376.
37. KOURY MJ. RCAS1, physiologic or pathologic mediator of apoptosis. Blood 2001;98:225-226.
38. SPIVAK JL. The blood in systemic disorders. Lancet 2000;355:1707-1712.